DGAP-News: INJEX Pharma AG signs exclusive distributor contract for Russia with MEDICI Ltd. / 30,000 INJEX 30 Systems and 7,000 SHIREEN Beauty Kits in the first year
(firmenpresse) - DGAP-News: INJEX Pharma AG / Key word(s): Contract
INJEX Pharma AG signs exclusive distributor contract for Russia with
MEDICI Ltd. / 30,000 INJEX 30 Systems and 7,000 SHIREEN Beauty Kits in
the first year
09.10.2012 / 14:54
---------------------------------------------------------------------
INJEX Pharma AG signs exclusive distributor contract for Russia with MEDICI
Ltd. / 30,000 INJEX 30 Systems and 7,000 SHIREEN Beauty Kits in the first
year
INJEX Pharma AG ISIN: DE000A0STYL7
Berlin, 09. October 2012
Berlin - INJEX Pharma AG, located in Berlin, has signed an exclusive
distributor agreement for sales of the needle free syringe INJEX 30 Systems
and new Poring-Method with the SHIREEN Beauty Kit with MEDICI Ltd., based
in the World Trade Center in Moscow, Russia.
The contract contains a minimum quantity commencing in year one with a
minimum of 30,000 INJEX 30 Systems and 7,000 SHIREEN Beauty Kits.
'We are excited to enter Russia with MEDICI Ltd. Russia has tremendous
demand for our technology. The initial shipment of 4,000 INJEX 30 Systems
and 700 SHIREEN Beauty Kits was triggered by MEDICI Ltd. meeting specific
financial and logistical contractual obligations.
We have strategically defined our roll-out for INJEX. The syringe without
a needle technology offers a safe and soft alternative for various medical
applications including the treatment of diabetes, local anesthetics, dental
procedures and vaccinations. Needle free technology is not just an
alternative for needle phobia. INJEX technological efficacy will benefit
providers in delivering superior patient centric care. Giving patients a
pain free alternative without mitigating efficacy makes sense.' Mr.
Alexander Novgorodov, General Manager, MEDICI Ltd.
'Simultaneously the innovative Poring-Method with the SHIREEN Beauty Kit
also offers huge market potential for the booming beauty market in Russia.'
Mr. Novgorodov
'The SHIREEN Poring-Method combined with the proprietary SHIREEN Fluid
helps to restore a profound long-lasting smoothing of first superficial
wrinkles on the face, neck, décolletéand back of the hands. 'The SHIREEN
PoreJet utilizes for the Poring-Method essential Poring-Tip, allowing
SHIREEN Fluid to be evenly sprayed through the pores and the outer skin
layers. Our new technology offers a pain-free, effective and long lasting
effect.' Andy Rösch, CEO of INJEX Pharma AG.
'The breakthrough SHIREEN Beauty-Kit will assist Russian service providers
and their patients in meeting the demand for the expanding beauty space.
It's an innovative painless application for people wanting to restore a
younger, fresher and more beautiful appearance without pain. Other
benefits include the avoidance of time-consuming treatments and unnecessary
potential risks associated with traditional use of needles. We are
confident this technology is needed and its time has arrived. Our initial
estimates are quite conservative and we have planned accordingly for upward
revisions in the short term to meet demand.' Mr. Novgorodov, MEDICI Ltd.
Contact:
Andy Rösch
CEO
INJEX Pharma AG
Buckower Damm 114
12349 Berlin
Tel.: 0049-30-53096768
andy.roesch(at)injex.com
www.injex.com
Sylwin Grinman
Managing Director
INJEX Pharma USA
1922 NE 119 RD
North Miami Beach - FL - 33181
USA
Tel.: +1 786 512 196 3
sylwin(at)injex.com
End of Corporate News
---------------------------------------------------------------------
09.10.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
188167 09.10.2012
Themen in dieser Pressemitteilung:
injex-pharma-ag-signs-exclusive-distributor-contract-for-russia-with-medici-ltd-30
000-injex-30-systems-and-7
000-shireen-beauty-kits-in-the-first-year
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="Pacific Potash Corporation's Merger Partner Announces LOI for the Sale of up to 50,000 Tonnes of Calcium Sulphate to ParaguayDatum: 09.10.2012 - 14:54 Uhr
Sprache: Deutsch
News-ID 190712
Anzahl Zeichen: 5338
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 391 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: INJEX Pharma AG signs exclusive distributor contract for Russia with MEDICI Ltd. / 30,000 INJEX 30 Systems and 7,000 SHIREEN Beauty Kits in the first year"
steht unter der journalistisch-redaktionellen Verantwortung von
INJEX Pharma AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
